• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX ITALIA S.P.A. VIDAS ANALYSER; VIDAS® ANALYSER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX ITALIA S.P.A. VIDAS ANALYSER; VIDAS® ANALYSER Back to Search Results
Model Number 99735
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Misdiagnosis (2159)
Event Type  Injury  
Event Description
On (b)(6) 2020, a customer in the united states notified biomérieux of a qcv detected failure which occurred at section a1 of their vidas® analyser (ref.99735, serial (b)(4)).The customer confirmed the most recent passing qcv test occurred on (b)(6) 2020 and performed a retrospective analysis for the impacted timeframe.The retrospective analysis identified one (1) procalcitonin (pct) sample was initially underestimated.The original test result obtained was <0.05 ng/ml, the repeat test obtained a value of > 2 ng/ml.The customer stated the underestimated result was reported to the physician, and treatment was withheld based upon the underestimated result of <0.05 ng/ml.Treatment of the patient was adjusted after obtaining the corrected value of > 2 ng/ml.Although there is no indication or report from the laboratory that the discrepant result led to any direct negative impact to the patient's state of health, the customer confirmed treatment of the patient was delayed based upon the erroneous underestimated pct result.Biomérieux will initiate an internal investigation.
 
Manufacturer Narrative
An investigation was initiated in response to a customer complaint of a qcv detected failure which occurred at section a1 of their vidas® analyser (ref.99735, serial (b)(6)).A qcv failure is not an abnormal behavior.It means that the qcv played its role as a functional control.This control is meant to detect residual risks, that are rare and sudden.Those risks are already present and accepted into the vidas system risk analysis.A field service engineer (fse) visited the customer site and investigated the issue.The cause for the qcv failure on section a1 was identified to be a clog in position a1.According to the biomérieux internal procedures, the fse performed several actions: pump test, then pump cleaning on the positions needed (position a1).After cleaning the positon a1 pump channel, the pump test passed.Leak test and qcv test performed in order to qualify the instrument.The tv1 results and r3 results were correct on all positions, after cleaning pump channel a1.The final qcv test passed and the customer's instrument was qualified for use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS ANALYSER
Type of Device
VIDAS® ANALYSER
Manufacturer (Section D)
BIOMERIEUX ITALIA S.P.A.
via di campigliano 58 / loc. p
firenze 50012
IT  50012
MDR Report Key10105030
MDR Text Key194681391
Report Number9615037-2020-00031
Device Sequence Number1
Product Code DEW
UDI-Device Identifier03573026140427
UDI-Public03573026140427
Combination Product (y/n)N
PMA/PMN Number
K891385
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 07/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number99735
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/08/2020
Initial Date FDA Received06/01/2020
Supplement Dates Manufacturer Received06/12/2020
Supplement Dates FDA Received07/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-